Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance.
about
The well-accepted notion that gene amplification contributes to increased expression still remains, after all these years, a reasonable but unproven assumptionDifferent Facets of Copy Number Changes: Permanent, Transient, and AdaptiveTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerImportant role of CYP2J2 in protein kinase inhibitor degradation: a possible role in intratumor drug disposition and resistancePotential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas.Collateral chemoresistance to anti-microtubule agents in a lung cancer cell line with acquired resistance to erlotinib.Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxelCo-treatment by docetaxel and vinblastine breaks down P-glycoprotein mediated chemo-resistance.Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxel.p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.Chemotherapy Resistance in Lung Cancer.Two different docetaxel resistant MCF-7 sublines exhibited different gene expression pattern.Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells.The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance.The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells.How does the chain length of PEG functionalized at the outer surface of mesoporous silica nanoparticles alter the uptake of molecules?
P2860
Q26746180-07039C1D-8095-47D6-923B-D90CC62BA1EBQ26769649-C8F510E1-E089-43F8-96C0-37305F6905F9Q28396304-6E07C17A-5D99-4CD9-83BE-48BCAEA1DCC9Q28538733-845DA960-8570-4BD5-95AB-9E75000E0AEDQ33511042-5A5191D6-75E5-4CF9-A4F3-B95AAB6E05F3Q35602423-549C2945-0669-42EF-9D90-25AE378AD879Q36521792-1D3F973F-674C-495A-AE7C-4FAB719ABDF5Q36805184-F1F20AFE-7074-426A-B305-00C95F6D122EQ36885663-40D477A1-E912-46DC-883E-846F7B48DC2DQ36946749-E7A17880-0035-45D2-B290-C9F66B4A1E51Q38669287-9937E2CC-A2AF-4873-AFF2-1408B96EC6A9Q39514723-40733F2C-2B89-42BA-B621-709507B4307DQ39567517-22941180-CE81-474C-B0DE-9B818B4B0507Q39744992-05F01526-956E-4BA5-BA81-A5BD3CAA8860Q47601279-C905AA9D-4E2D-4378-8F94-333F548AE8D7Q58161541-6AA2BA24-8466-4661-9209-A58B7A59E071
P2860
Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Gene amplification and express ...... cquired paclitaxel resistance.
@en
type
label
Gene amplification and express ...... cquired paclitaxel resistance.
@en
prefLabel
Gene amplification and express ...... cquired paclitaxel resistance.
@en
P2093
P1476
Gene amplification and express ...... cquired paclitaxel resistance.
@en
P2093
Hiromichi Terashima
Kiyoaki Sakata
Kunio Kitada
Nami Yabuki
Tomoaki Yamasaki
Toshihiko Fujii
Toshiyuki Mio
Youko Miyazaki
P356
10.1016/J.CANCERGENCYTO.2006.07.020
P577
2007-02-01T00:00:00Z